Efficient Long-term Gene Transfer into Muscle Tissue of Immunocompetent Mice by Adeno-associated Virus Vector

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1996 Nov 1

PMID 8892935

Citations 265

Authors

X Xiao

J Li

R J Samulski

Affiliations

Soon will be listed here.

Abstract

Muscle-directed gene transfer is being considered for the treatment of several metabolic diseases, including hemophilia and Duchene's muscular dystrophy. Previous efforts to target this tissue for somatic delivery with various vector systems have resulted in transient expression due to silencing of the transgene or to an immune response against the vector-transduced cells. We introduced recombinant adeno-associated virus vector (rAAV) carrying a lacZ reporter into muscle tissue of immunocompetent mice. The lacZ reporter gene was efficiently transduced and expressed with no evidence of a cellular immune response. Moreover, gene expression persisted for more than 1.5 years. Molecular characterization of rAAV vector DNA suggests a mechanism for persistence, since vector episomes convert to high-molecular-weight genomic DNA. These data provide the first report for establishing long-term gene transduction into mammalian muscle cells in vivo without the need for immune modulation of the organism.

Citing Articles

Mesenchymal Stem Cells Expressing Baculovirus-Engineered Brain-Derived Neurotrophic Factor Improve Peripheral Nerve Regeneration in a Rat Model.

Lee W, Choi S, Shin Y, Kim J Tissue Eng Regen Med. 2025; .

PMID: 39962026 DOI: 10.1007/s13770-025-00703-2.

A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice.

Tang X, Wang H, Yin Y, Zhong G Gene Ther. 2025; .

PMID: 39939797 DOI: 10.1038/s41434-025-00519-8.

Oxidized mRNA Lipid Nanoparticles for Chimeric Antigen Receptor Monocyte Engineering.

Mukalel A, Hamilton A, Billingsley M, Li J, Thatte A, Han X Adv Funct Mater. 2024; 34(27).

PMID: 39628840 PMC: 11611297. DOI: 10.1002/adfm.202312038.

Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy.

Dong C, Tan D, Sun H, Li Z, Zhang L, Zheng Y Curr Issues Mol Biol. 2024; 46(10):11548-11579.

PMID: 39451566 PMC: 11506767. DOI: 10.3390/cimb46100686.

Triple Combinations of AAV9-Vectors Encoding Anti-HIV bNAbs Provide Long-Term In Vivo Expression of Human IgG Effectively Neutralizing Pseudoviruses from HIV-1 Global Panel.

Shipulin G, Glazkova D, Urusov F, Belugin B, Dontsova V, Panova A Viruses. 2024; 16(8).

PMID: 39205270 PMC: 11359378. DOI: 10.3390/v16081296.

References

Kaplitt M, Leone P, Samulski R, Xiao X, Pfaff D, OMalley K . Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994; 8(2):148-54. DOI: 10.1038/ng1094-148. View

Levy M, Barron L, Meyer K, Szoka Jr F . Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 1996; 3(3):201-11. View

Halbert C, Alexander I, Wolgamot G, Miller A . Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol. 1995; 69(3):1473-9. PMC: 188736. DOI: 10.1128/JVI.69.3.1473-1479.1995. View

Dai Y, Schwarz E, Gu D, Zhang W, Sarvetnick N, Verma I . Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A. 1995; 92(5):1401-5. PMC: 42527. DOI: 10.1073/pnas.92.5.1401. View

Yang Y, Ertl H, Wilson J . MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1994; 1(5):433-42. DOI: 10.1016/1074-7613(94)90074-4. View

Yang Y, Li Q, Ertl H, Wilson J . Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995; 69(4):2004-15. PMC: 188865. DOI: 10.1128/JVI.69.4.2004-2015.1995. View

Lochmuller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B . Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther. 1994; 5(12):1485-91. DOI: 10.1089/hum.1994.5.12-1485. View

Flotte T, Solow R, Afione S, Carter B, Guggino W . An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 1995; 2(1):29-37. View

Berns K, Linden R . The cryptic life style of adeno-associated virus. Bioessays. 1995; 17(3):237-45. DOI: 10.1002/bies.950170310. View

10.

Russell D, Alexander I, Miller A . DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci U S A. 1995; 92(12):5719-23. PMC: 41768. DOI: 10.1073/pnas.92.12.5719. View

11.

Miller J, Boyce F . Gene therapy by and for muscle cells. Trends Genet. 1995; 11(5):163-5. DOI: 10.1016/s0168-9525(00)89032-0. View

12.

Yang Y, Wilson J . Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol. 1995; 155(5):2564-70. View

13.

Goldman M, Wilson J . Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol. 1995; 69(10):5951-8. PMC: 189490. DOI: 10.1128/JVI.69.10.5951-5958.1995. View

14.

Flotte T, Carter B . Adeno-associated virus vectors for gene therapy. Gene Ther. 1995; 2(6):357-62. View

15.

Fang B, Eisensmith R, Wang H, Kay M, CROSS R, Landen C . Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther. 1995; 6(8):1039-44. DOI: 10.1089/hum.1995.6.8-1039. View

16.

Kay M, Holterman A, Meuse L, Gown A, Ochs H, Linsley P . Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet. 1995; 11(2):191-7. DOI: 10.1038/ng1095-191. View

17.

Acsadi G, Jani A, Huard J, Blaschuk K, Massie B, Holland P . Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1994; 1(5):338-40. View

18.

Blau H, Springer M . Muscle-mediated gene therapy. N Engl J Med. 1995; 333(23):1554-6. DOI: 10.1056/NEJM199512073332308. View

19.

Fisher K, Gao G, Weitzman M, Dematteo R, Burda J, Wilson J . Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol. 1996; 70(1):520-32. PMC: 189840. DOI: 10.1128/JVI.70.1.520-532.1996. View

20.

Huard J, Lochmuller H, Acsadi G, Jani A, Holland P, Guerin C . Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol. 1995; 62(2):131-43. DOI: 10.1006/exmp.1995.1015. View